Dr. Bettina Hoeppner, PhD, MS
Claim this profileStudies Smoking Cessation
Studies Smoking
1 reported clinical trial
1 drug studied
More about Bettina Hoeppner, PhD, MS
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Bettina Hoeppner, PhD, MS has experience with
- Smiling Instead Of Smoking - HIV
Breakdown of trials Bettina Hoeppner, PhD, MS has run
Smoking Cessation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bettina Hoeppner, PhD, MS specialize in?
Bettina Hoeppner, PhD, MS focuses on Smoking Cessation and Smoking. In particular, much of their work with Smoking Cessation has involved treating patients, or patients who are undergoing treatment.
Is Bettina Hoeppner, PhD, MS currently recruiting for clinical trials?
No, Bettina Hoeppner, PhD, MS is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Bettina Hoeppner, PhD, MS has studied deeply?
Yes, Bettina Hoeppner, PhD, MS has studied treatments such as Smiling instead of Smoking - HIV.
What is the best way to schedule an appointment with Bettina Hoeppner, PhD, MS?
Apply for one of the trials that Bettina Hoeppner, PhD, MS is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.